Key Points
- Healthcare Holding B.V. Gilde sold 10,751 Shoulder Innovations shares at an average price of $22.71, generating $244,155.21. The sale reduced its direct stake by 0.46% to 2.32 million shares valued at approximately $52.7 million.
- Gilde also sold more than 148,000 additional shares in transactions from July 30 through August 4, indicating a broader pattern of insider selling.
- Shoulder Innovations shares opened at $22.56, near their 12-month high, while analysts maintained a “Moderate Buy” consensus with an average price target of $22.00; the company reported quarterly revenue of $16.71 million and an adjusted loss of $0.41 per share.
Shoulder Innovations, Inc. (NYSE:SI - Get Free Report) major shareholder Healthcare Holding B.V. Gilde sold 10,751 shares of the business's stock in a transaction dated Monday, August 3rd. The stock was sold at an average price of $22.71, for a total transaction of $244,155.21. Following the sale, the insider directly owned 2,321,452 shares in the company, valued at $52,720,174.92. The trade was a 0.46% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Major shareholders that own at least 10% of a company's shares are required to disclose their sales and purchases with the SEC.
Healthcare Holding B.V. Gilde also recently made the following trade(s):
- On Tuesday, August 4th, Healthcare Holding B.V. Gilde sold 99,812 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.77, for a total transaction of $2,272,719.24.
- On Friday, July 31st, Healthcare Holding B.V. Gilde sold 20,034 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.73, for a total transaction of $455,372.82.
- On Thursday, July 30th, Healthcare Holding B.V. Gilde sold 28,245 shares of Shoulder Innovations stock. The stock was sold at an average price of $23.36, for a total value of $659,803.20.
Shoulder Innovations Stock Down 0.6%
SI stock opened at $22.56 on Thursday. Shoulder Innovations, Inc. has a twelve month low of $10.92 and a twelve month high of $24.59. The company has a quick ratio of 10.04, a current ratio of 11.81 and a debt-to-equity ratio of 0.11. The firm has a market cap of $467.89 million and a PE ratio of -0.14. The business has a 50 day moving average of $19.65 and a 200 day moving average of $15.98.
Shoulder Innovations (NYSE:SI - Get Free Report) last released its earnings results on Wednesday, May 13th. The company reported ($0.41) EPS for the quarter, topping the consensus estimate of ($0.44) by $0.03. Shoulder Innovations had a negative return on equity of 35.11% and a negative net margin of 81.78%.The business had revenue of $16.71 million for the quarter. On average, research analysts forecast that Shoulder Innovations, Inc. will post -1.67 EPS for the current fiscal year.
Analyst Ratings Changes
A number of analysts have weighed in on SI shares. Weiss Ratings upgraded shares of Shoulder Innovations from a "sell (d-)" rating to a "sell (d)" rating in a research note on Monday. UBS Group initiated coverage on Shoulder Innovations in a research report on Tuesday, July 28th. They issued a "buy" rating and a $27.00 price objective on the stock. Finally, Piper Sandler reiterated an "overweight" rating and set a $19.00 target price (up from $18.00) on shares of Shoulder Innovations in a research note on Friday, May 8th. Six investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $22.00.
Check Out Our Latest Research Report on Shoulder Innovations
Institutional Trading of Shoulder Innovations
Institutional investors have recently made changes to their positions in the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new stake in shares of Shoulder Innovations in the third quarter worth approximately $28,000. Rhumbline Advisers bought a new position in Shoulder Innovations during the third quarter valued at approximately $54,000. Wells Fargo & Company MN boosted its holdings in Shoulder Innovations by 66.3% in the fourth quarter. Wells Fargo & Company MN now owns 5,250 shares of the company's stock worth $75,000 after purchasing an additional 2,094 shares during the last quarter. Renaissance Technologies LLC purchased a new stake in Shoulder Innovations in the fourth quarter worth approximately $176,000. Finally, Blue Trust Inc. bought a new stake in Shoulder Innovations in the 1st quarter worth approximately $228,000.
Shoulder Innovations Company Profile
(
Get Free Report)
Shoulder Innovations (NYSE:SI) is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.
In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
